U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513363) titled 'The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency' on April 01.
Brief Summary: The primary aim of this study is to evaluate the role of three specific urinary proteins-RhoA, Nerve Growth Factor (NGF), and Brain-Derived Neurotrophic Factor (BDNF)-as potential biomarkers for the diagnosis and follow-up of children aged 4-18 diagnosed with Overactive Bladder (OAB) and Vitamin D deficiency.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Overactive Bladder
Vitamin D Deficiency
Intervention:
BEHAVIORAL: Urotherapy
Diagnosis and first-line treatment (urotherapy) will be con...